George Horner Joins Sofinnova Ventures

George Horner has joined Sofinnova Ventures as an executive-in-residence, according to VentureWire. He is the former CEO of Prestwick Pharmaceuticals, a Sofinnova-backed company sold last year to Biovail Corp. for $100 million in cash. www.sofinnova.com

12 March 2009•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail